Correlation Between Dyne Therapeutics and Nuvalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Nuvalent, you can compare the effects of market volatilities on Dyne Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Nuvalent.

Diversification Opportunities for Dyne Therapeutics and Nuvalent

DyneNuvalentDiversified AwayDyneNuvalentDiversified Away100%
0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dyne and Nuvalent is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Nuvalent go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Nuvalent

Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 1.65 times less return on investment than Nuvalent. In addition to that, Dyne Therapeutics is 1.46 times more volatile than Nuvalent. It trades about 0.03 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.07 per unit of volatility. If you would invest  2,787  in Nuvalent on December 12, 2024 and sell it today you would earn a total of  4,238  from holding Nuvalent or generate 152.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Nuvalent

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50-40-30-20-100
JavaScript chart by amCharts 3.21.15DYN NUVL
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar152025
Nuvalent 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar65707580859095

Dyne Therapeutics and Nuvalent Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-9.41-7.05-4.68-2.320.01.863.725.597.45 0.020.030.040.050.06
JavaScript chart by amCharts 3.21.15DYN NUVL
       Returns  

Pair Trading with Dyne Therapeutics and Nuvalent

The main advantage of trading using opposite Dyne Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.
The idea behind Dyne Therapeutics and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules